{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T16:25:03Z","timestamp":1784823903662,"version":"3.55.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Pediatr"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s12519-020-00370-4","type":"journal-article","created":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T17:05:01Z","timestamp":1591117501000},"page":"31-39","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Bartter\u2019s syndrome: clinical findings, genetic causes and therapeutic approach"],"prefix":"10.1007","volume":"17","author":[{"given":"Flavia Cristina Carvalho","family":"Mrad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00edlvia Bouissou Morais","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Alberto Wanderley","family":"de Menezes Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro Versiani","family":"dos Anjos Menezes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9222-3882","authenticated-orcid":false,"given":"Ana Cristina","family":"Sim\u00f5es-e-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,1]]},"reference":[{"key":"370_CR1","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0002-9343(62)90214-0","volume":"33","author":"FC Bartter","year":"1962","unstructured":"Bartter FC, Pronove P, Gill JR Jr, MacCardle RC. Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis. A new syndrome. Am J Med. 1962;33:811\u201328.","journal-title":"Am J Med"},{"key":"370_CR2","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1590\/S0101-28002012000100014","volume":"34","author":"GS Dos Reis","year":"2011","unstructured":"Dos Reis GS, de Miranda DM, de Barros Pereira PC, Sarubi HC, Rodrigues LB, de Marco LAC, et al. Application of molecular biology at the approach of Batter\u2019syndrome: case report. J Bras Nefrol. 2011;34:82\u20136.","journal-title":"J Bras Nefrol"},{"issue":"Suppl 1","key":"370_CR3","first-page":"S58","volume":"25","author":"S Hussain","year":"2015","unstructured":"Hussain S, Tarar SH, Al-Muhaizaen M. A Rare disorder with common clinical presentation: neonatal Bartter syndrome. J Coll Phys Surg Pak. 2015;25(Suppl 1):S58\u201360.","journal-title":"J Coll Phys Surg Pak"},{"key":"370_CR4","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/MNH.0000000000000346","volume":"26","author":"M K\u00f6mhoff","year":"2017","unstructured":"K\u00f6mhoff M, Lagmani K. Pathophysology of antenatal Bartter\u2019s syndrome. Curr Opin Nephrol Hypertens. 2017;26:419\u201325.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"370_CR5","doi-asserted-by":"crossref","first-page":"101614","DOI":"10.18632\/oncotarget.21355","volume":"8","author":"Y Han","year":"2017","unstructured":"Han Y, Lin Y, Sun Q, Wang S, Gao Y, Shao L. Mutation spectrum of chinese patients with Bartter syndrome. Oncotarget. 2017;8:101614\u201322.","journal-title":"Oncotarget"},{"key":"370_CR6","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1056\/NEJMoa1507629","volume":"374","author":"K Laghmani","year":"2016","unstructured":"Laghmani K, Beck BB, Yang SS, Seaayfan E, Wenzel A, Reusch B, et al. Polyhydramnios, transient antenatal Bartter\u2019s syndrome, and MAGED2 mutations. N Engl J Med. 2016;374:1853\u201363.","journal-title":"N Engl J Med"},{"key":"370_CR7","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/MNH.0000000000000422","volume":"27","author":"M K\u00f6mhoff","year":"2018","unstructured":"K\u00f6mhoff M, Lagmani K. MAGED2: a novel of antenatal Bartter\u2019s syndrome. Curr Opin Nephrol Hypertens. 2018;27:323\u20138.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"370_CR8","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1007\/s00467-011-1871-4","volume":"26","author":"HW Seyberth","year":"2011","unstructured":"Seyberth HW, Schlingmann KP. Bartter- and Gitelman-like syndromes: salt-losing tubulopathies with loop or DCT defects. Pediatr Nephrol. 2011;26:1789\u2013802.","journal-title":"Pediatr Nephrol"},{"key":"370_CR9","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/ng.118","volume":"40","author":"W Ji","year":"2008","unstructured":"Ji W, Foo JN, O'Roak BJ, Zhao H, Larson MG, Simon DB, et al. Rare independent mutations in renal salt handling genes contribute to blood pressure variation. Nat Genet. 2008;40:592\u20139.","journal-title":"Nat Genet"},{"key":"370_CR10","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000094001","volume":"104","author":"R Kleta","year":"2006","unstructured":"Kleta R, Bockenhauerc D. Bartter syndromes and other salt-losing tubulopathies. Nephron Physiol. 2006;104:73\u201380.","journal-title":"Nephron Physiol"},{"key":"370_CR11","doi-asserted-by":"crossref","unstructured":"Soares SBM, de Menezes Silva LAW, de Carvalho Mrad FC, Sim\u00f5es E Silva AC. World J Pediatr. 2019;15:422\u201331.","DOI":"10.1007\/s12519-019-00260-4"},{"key":"370_CR12","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s40620-020-00700-9","volume":"33","author":"GM Rossi","year":"2020","unstructured":"Rossi GM, Regolisti G, Peyronel F, Fiaccadori E. Recent insights into sodium and potassium handling by the aldosterone-sensitive distal nephron: implications on pathophysiology and drug discovery. J Nephrol. 2020;33:447\u201366.","journal-title":"J Nephrol"},{"key":"370_CR13","first-page":"6","volume":"1","author":"H Fazilaty","year":"2014","unstructured":"Fazilaty H, Behnam B. Molecular genetics of Bartter syndrome. J Ped Nephrol. 2014;1:6\u201314.","journal-title":"J Ped Nephrol"},{"key":"370_CR14","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.bone.2017.01.011","volume":"97","author":"S Wongsaengsak","year":"2017","unstructured":"Wongsaengsak S, Vidmar AP, Addala A, Kamil ES, Sequeira P, Fass B, et al. A novel SLC12A1 gene mutation associated with hyperparathyroidism, hypercalcemia, nephrogenic diabetes insipidus and nephrocalcinosis in four patients. Bone. 2017;97:121\u20135.","journal-title":"Bone"},{"key":"370_CR15","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/ng1097-171","volume":"17","author":"DB Simon","year":"1997","unstructured":"Simon DB, Bindra RS, Mansfield TA, Nelson-Williams C, Mendon\u00e7a E, Stone R, et al. Mutations in the chloride channel gene, CLCNKB, cause Bartter\u2019s syndrome type III. Nat Genet. 1997;17:171\u20138.","journal-title":"Nat Genet"},{"key":"370_CR16","doi-asserted-by":"crossref","first-page":"e0173581","DOI":"10.1371\/journal.pone.0173581","volume":"12","author":"A Garcia Casta\u00f1o","year":"2017","unstructured":"Garcia Casta\u00f1o A, de Nanclares GP, Madariaga L, Aguirre M, Madrid A, Chocr\u00f3n S, et al. Poor phenotype-genotype association in a large series of patients with type III Bartter syndrome. PLoS One. 2017;12:e0173581.","journal-title":"PLoS One"},{"key":"370_CR17","doi-asserted-by":"crossref","first-page":"5573","DOI":"10.1113\/JP274344","volume":"15","author":"CJ Cheng","year":"2017","unstructured":"Cheng CJ, Lo YF, Chen JC, Huang CL, Lin SH. Functional severity of CLCNKB mutations with phenotypes in patients with classic Bartter\u2019s syndrome. J Physiol. 2017;15:5573\u201386.","journal-title":"J Physiol"},{"key":"370_CR18","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00424-013-1370-5","volume":"466","author":"N Markadieu","year":"2014","unstructured":"Markadieu N, Delpire E. Physiology and pathophysiology of SLC12A1\/2 transporters. Pflugers Arch. 2014;466:91\u2013105.","journal-title":"Pflugers Arch"},{"key":"370_CR19","doi-asserted-by":"crossref","first-page":"F1198","DOI":"10.1152\/ajprenal.00288.2012","volume":"304","author":"K Mederle","year":"2013","unstructured":"Mederle K, Mutig K, Paliege A, Carota I, Bachmann S, Castrop H, et al. Loss of WNK3 is compensated for by the WNK1\/SPAK axis in the kidney of the mouse. Am J Physiol Renal Physiol. 2013;304:F1198\u2013209.","journal-title":"Am J Physiol Renal Physiol"},{"key":"370_CR20","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s12519-015-0016-4","volume":"11","author":"E Koulouridis","year":"2015","unstructured":"Koulouridis E, Koulouridis I. Molecular pathophysiology of Bartter\u2019s and Gitelman\u2019s syndrome. World J Pediatr. 2015;11:113\u201325.","journal-title":"World J Pediatr"},{"key":"370_CR21","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1515\/jpem-2014-0188","volume":"28","author":"I Gross","year":"2015","unstructured":"Gross I, Siedner-Weintraub Y, Simckes A, Gillis D. Antenatal Bartter syndrome presenting as hyperparathyroidism with hypercalcemia and hypercalciuria: a case report and review. J Pediatr Endocrinol Metab. 2015;28:943\u20136.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"370_CR22","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1210\/jc.2016-1211","volume":"101","author":"D Li","year":"2016","unstructured":"Li D, Tian L, Hou C, Kim CE, Hakonarson H, Levine MA. Association of mutations in SLC12A1 encoding the NKCC2 cotransporter with neonatal primary hyperparathyroidism. J Clin Endocrinol Metab. 2016;101:2196\u2013200.","journal-title":"J Clin Endocrinol Metab"},{"key":"370_CR23","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1007\/s12020-019-01856-6","volume":"64","author":"Y Han","year":"2019","unstructured":"Han Y, Zhao X, Wang S, Wang C, Tian D, Lang Y, et al. Eleven novel SLC12A1 variants and an exonic mutation cause exon skippinh in Bartter syndrome type I. Endocrine. 2019;64:708\u201318.","journal-title":"Endocrine"},{"key":"370_CR24","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00439-019-01978-x","volume":"138","author":"A Amar","year":"2019","unstructured":"Amar A, Majmundar AJ, Ullah I, Afzal A, Braun DA, Shril S, et al. Gene panel sequencing identifies a likely monogenic cause in 7% of 235 Pakistani families with nephrolithiasis. Hum Genet. 2019;138:211\u20139.","journal-title":"Hum Genet"},{"key":"370_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s13730-020-00464-y","author":"P Khandelwal","year":"2020","unstructured":"Khandelwal P, Sabanadesan J, Sinha A, Hari P, Bagga A. Isolated nephrocalcinosis due to compound heterozygous mutations in renal outer medullary potassium channel. CEN Case Rep. 2020. https:\/\/doi.org\/10.1007\/s13730-020-00464-y.","journal-title":"CEN Case Rep"},{"key":"370_CR26","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3389\/fgene.2020.00081","volume":"11","author":"C Wang","year":"2020","unstructured":"Wang C, Han Y, Zhou J, Zheng B, Zhou W, Bao H, et al. Splicing characterization of CLCNKB variants in four patients with type III Bartter syndrome. Front Genet. 2020;11:81.","journal-title":"Front Genet"},{"key":"370_CR27","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/humu.23962","volume":"41","author":"Y Bignon","year":"2020","unstructured":"Bignon Y, Sakhi I, Bitam S, Bakouh N, Keck M, Frachon N, et al. Analysis of CLCNKB mutations at dimer-interface, calcium-binding site, and pore reveals a variety of functional alterations in ClC-Kb channel leading to Bartter syndrome. Hum Mutat. 2020;41:774\u201385.","journal-title":"Hum Mutat"},{"key":"370_CR28","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1056\/NEJMoa032843","volume":"350","author":"KP Schlingmann","year":"2004","unstructured":"Schlingmann KP, Konrad M, Jeck N, Waldegger P, Reinalter SC, Holder M, et al. Salt wasting and deafness resulting from mutations two chloride channels. N Engl J Med. 2004;350:1314\u20139.","journal-title":"N Engl J Med"},{"key":"370_CR29","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1002\/lary.23532","volume":"122","author":"G Kontorinis","year":"2012","unstructured":"Kontorinis G, Giesemann AM, Iliodromiti Z, Weidermann J, Aljeraisi T, Schwab B. Treating hearing loss in patients with infantile Bartter syndrome. Laryngoscope. 2012;122:2524\u20138.","journal-title":"Laryngoscope."},{"key":"370_CR30","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ijporl.2018.07.010","volume":"113","author":"S Elrharchi","year":"2018","unstructured":"Elrharchi S, Riahi Z, Salime S, Nahili H, Rouba H, Kabine M, et al. Two novel homozygous missense mutations identified in the BSND gene in Moraccan patients with Bartter\u2019s syndrome. Int J Pediatr Otornhinolaryngol. 2018;113:46\u201350.","journal-title":"Int J Pediatr Otornhinolaryngol"},{"key":"370_CR31","doi-asserted-by":"crossref","first-page":"5970","DOI":"10.1074\/jbc.RA119.011049","volume":"295","author":"N Gorinski","year":"2020","unstructured":"Gorinski N, Wojciechowski D, Guseva D, Galil DA, Mueller FE, Wirth A, et al. DHHC7-mediated palmitoylation of the accessory protein barttin critically regulates the functions of ClC-K chloride channels. J Biol Chem. 2020;295:5970\u201383.","journal-title":"J Biol Chem"},{"key":"370_CR32","doi-asserted-by":"crossref","first-page":"242","DOI":"10.2215\/CJN.05670517","volume":"13","author":"A Legrad","year":"2018","unstructured":"Legrad A, Treard C, Rocelin I, Dreux S, Bertholet-Thomas A, Borux F, et al. Prevalence of novel MAGED2 mutations in antenatal Bartter syndrome. Clin J Am Soc Nephrol. 2018;13:242\u201350.","journal-title":"Clin J Am Soc Nephrol"},{"key":"370_CR33","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/boc.201400069","volume":"107","author":"M Carmosino","year":"2015","unstructured":"Carmosino M, Gerbino A, Hnedy GN, Torretta S, Rizzo F, Debellis L, et al. NKCC2 activity is inhibited by the Bartter\u2019s syndrome type 5 gain-of-fucntion CaR-A843E mutant in renal cells. Bio Cell. 2015;107:98\u2013110.","journal-title":"Bio Cell"},{"key":"370_CR34","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/pd.5038","volume":"38","author":"AN Abou Tayoun","year":"2018","unstructured":"Abou Tayoun AN, Spinner NB, Rehm HL, Green RC, Bianchi DW. Prenatal DNA sequencing: clinical, counseling and diagnostic laboratory considerations. Prenat Diagn. 2018;38:26\u201332.","journal-title":"Prenat Diagn"},{"key":"370_CR35","first-page":"857136","volume":"2012","author":"YR Bhat","year":"2012","unstructured":"Bhat YR, Vinayaka G, Sreelakshmi K. Antenatal Bartter syndrome: a review. Int J Pediatr. 2012;2012:857136.","journal-title":"Int J Pediatr"},{"key":"370_CR36","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1093\/ndt\/gfn689","volume":"24","author":"K Brochard","year":"2009","unstructured":"Brochard K, Boyer O, Blanchard A, Loirat C, Niaudet P, Macher MA, et al. Phenotype-genotype correlation in antenatal and antenatal variants of Bartter syndrome. Nephrol Dial Transplant. 2009;24:1455\u201364.","journal-title":"Nephrol Dial Transplant"},{"key":"370_CR37","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fped.2018.00051","volume":"6","author":"M Meyer","year":"2018","unstructured":"Meyer M, Berrios M, Lo C. Transient antenatal Bartter\u2019s syndrome: a case report. Front Pediatr. 2018;6:51.","journal-title":"Front Pediatr"},{"key":"370_CR38","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1203\/PDR.0b013e3181ca038d","volume":"67","author":"A Garnier","year":"2010","unstructured":"Garnier A, Dreux S, Vargas-Poussou R, Oury JF, Benachi A, Deschenes G, et al. Bartter syndrome prenatal diagnosis based on amniotic fluid biochemical analysis. Pediatr Res. 2010;67:300\u20133.","journal-title":"Pediatr Res"},{"key":"370_CR39","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.4103\/1319-2442.215121","volume":"28","author":"D Hegde","year":"2017","unstructured":"Hegde D, Mondkar J, Abdagire N. Neonatal Bartter syndrome in an extremely low birth weigth baby. Saudi J Kidney Dis Transpl. 2017;28:1162\u20134.","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"370_CR40","doi-asserted-by":"crossref","first-page":"230","DOI":"10.12659\/AJCR.883446","volume":"13","author":"H Sakalli","year":"2012","unstructured":"Sakalli H, Bucak HI. Type IV neonatal Bartter syndrome complicated with congenital chloride diarrhea. Am J Case Rep. 2012;13:230\u20133.","journal-title":"Am J Case Rep"},{"key":"370_CR41","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.kint.2016.09.046","volume":"91","author":"A Blanchard","year":"2017","unstructured":"Blanchard A, Bockenhauer D, Bolignano D, Caio LA, Cosyns E, Devuyst O, et al. Gitelman syndrome: consensus and guidance from a kidney disease: improving global outcomes (KDIGO) contorversies conference. Kidney Int. 2017;91:24\u201333.","journal-title":"Kidney Int"},{"key":"370_CR42","doi-asserted-by":"crossref","first-page":"437","DOI":"10.32641\/rchped.v90i4.932","volume":"90","author":"FCL de la G\u00f3mez","year":"2019","unstructured":"de la G\u00f3mez FCL, Novoa PJM, Caviedes RN. Bartter syndrome: an infrequent tubulopathy of prenatal onset. Rev Chil Pediatr. 2019;90:437\u201342.","journal-title":"Rev Chil Pediatr."},{"key":"370_CR43","doi-asserted-by":"crossref","first-page":"160","DOI":"10.4132\/jptm.2015.08.31","volume":"50","author":"EJ Cha","year":"2016","unstructured":"Cha EJ, Hwang WM, Yun SR, Park MH. An adult case of Bartter syndrome type III presenting with proteinuria. J Pathol Transl Med. 2016;50:160\u20134.","journal-title":"J Pathol Transl Med"},{"key":"370_CR44","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3345\/kjp.2011.54.1.36","volume":"54","author":"SE Lee","year":"2011","unstructured":"Lee SE, Han KH, Jung YH, Lee HK, Kang HG, Moon KC, et al. Renal transplantation in a patient with Bartter syndrome and glomerulosclerosis. Korean J Pediatr. 2011;54:36\u20139.","journal-title":"Korean J Pediatr"},{"key":"370_CR45","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/MAJ.0b013e31819f1ed8","volume":"338","author":"A Luqman","year":"2009","unstructured":"Luqman A, Kazmi A, Wall BM. Bartter's syndrome in pregnancy: review of potassium homeostasis in gestation. Am J Med Sci. 2009;338:500\u20134.","journal-title":"Am J Med Sci"},{"key":"370_CR46","doi-asserted-by":"crossref","first-page":"227","DOI":"10.4103\/0971-4065.179367","volume":"26","author":"ACV Kumar","year":"2016","unstructured":"Kumar ACV, Reddy MHK, Chaitanya V, Lakshmi BS, Ram R, Kumar VS. Bartter\u2019s syndrome in a geriatric patient. Indian J Nephrol. 2016;26:227\u20138.","journal-title":"Indian J Nephrol"},{"key":"370_CR47","first-page":"65","volume":"14","author":"S Yagub","year":"2020","unstructured":"Yagub S, Arif MS. A case of Bartter\u2019s syndrome presenting in adulthood. Iran J Kidney Dis. 2020;14:65\u20137.","journal-title":"Iran J Kidney Dis"},{"key":"370_CR48","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.kint.2017.10.016","volume":"93","author":"EJ Ashtons","year":"2018","unstructured":"Ashtons EJ, Legrand A, Benoit V, Roncelin I, Venisse A, Zennaro MC, et al. Simultaneous sequencing of 37 genes identified causative mutations in the majority of children with renal tubulopathies. Kidney Int. 2018;93:961\u20137.","journal-title":"Kidney Int"},{"key":"370_CR49","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.14481119","author":"ML Downie","year":"2020","unstructured":"Downie ML, Lopez Garcia SC, Kleta R, Bockenhauer D. Inherited tubulopathies of the kidney: insights from genetics. Clin J Am Soc Nephrol. 2020. https:\/\/doi.org\/10.2215\/CJN.14481119.","journal-title":"Clin J Am Soc Nephrol"},{"key":"370_CR50","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1016\/j.kint.2019.08.027","volume":"96","author":"M Hureaux","year":"2019","unstructured":"Hureaux M, Ashton E, Dahan K, Houillier P, Blanchard A, Cormier C, et al. High-throughput sequencing contributes to the diagnosis of tubulopathies and familial hypercalcemia hypocalciuria in adults. Kidney Int. 2019;96:1408\u201316.","journal-title":"Kidney Int"},{"key":"370_CR51","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12881-018-0527-7","volume":"19","author":"Y Chen","year":"2018","unstructured":"Chen Y, Zhang Z, Lin X, Pan Q, Zheng F, Li H. A novel compound heterozygous variant of the SLC12A13 gene in Gitelman syndrome pedigree. BMC Med Genet. 2018;19:17.","journal-title":"BMC Med Genet"},{"key":"370_CR52","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2147\/IJNRD.S155397","volume":"11","author":"CT da Silva","year":"2018","unstructured":"da Silva CT, Heilberg IP. Bartter syndrome: causes, diagnosis and treatment. Int J Nephrol Renovasc Dis. 2018;11:291\u2013301.","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"370_CR53","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1093\/ckj\/sfx033","volume":"10","author":"B Gollasch","year":"2017","unstructured":"Gollasch B, Anistan YM, Canaan-Kuhl S, Gollasch M. Late-onset Bartter syndrome type II. Clin Kidney J. 2017;10:594\u20139.","journal-title":"Clin Kidney J"},{"key":"370_CR54","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1007\/s00467-004-1527-8","volume":"19","author":"MH Vaisbich","year":"2004","unstructured":"Vaisbich MH, Fujimura MD, Koch VH. Bartter syndrome: benefits and side effects of long-term treatment. Pediatr Nephrol. 2004;19:858\u201363.","journal-title":"Pediatr Nephrol"},{"key":"370_CR55","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S0009-9236(01)78384-1","volume":"70","author":"RM N\u00fcsing","year":"2001","unstructured":"N\u00fcsing RM, Reinalter SC, Peters M, K\u00f6mhoff M, Seyberth HW. Pathogenetic role of cyclooxygenase-2 in hyperprostaglandin E syndrome\/antenatal Bartter syndrome: therapeutic use of the cyclooxygenase-2 inhibitor nimesulide. Clin Pharmacol Ther. 2001;70:384\u201390.","journal-title":"Clin Pharmacol Ther"},{"key":"370_CR56","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1001\/jama.286.8.954","volume":"286","author":"D Mukherjee","year":"2001","unstructured":"Mukherjee D, Nissen SE, Topol EJ. Risk of cardiovascular events associated with selective COX-2 inhibitors. JAMA. 2001;286:954\u20139.","journal-title":"JAMA"},{"key":"370_CR57","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jped.2014.01.012","volume":"90","author":"CLP Nascimento","year":"2014","unstructured":"Nascimento CLP, Garcia CL, Schvartsmana BGS, Vaisbich MH. Treatment of Bartter syndrome. Unsolved issue. J Pediatr (Rio J). 2014;90:512\u20137.","journal-title":"J Pediatr (Rio J)."},{"key":"370_CR58","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1111\/ped.13100","volume":"58","author":"R Nagao","year":"2016","unstructured":"Nagao R, Suzuki S, Kawashima H, Nozu K, Iijima K. Acute kidney injury in type 3 Bartter syndrome: angiotensin-converting enzyme inhibitors as a cause. Pediatr Int. 2016;58:1373\u20134.","journal-title":"Pediatr Int"},{"key":"370_CR59","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s11255-019-02351-7","volume":"52","author":"M Mazaheri","year":"2020","unstructured":"Mazaheri M, Assadi F, Sadeghi-Bojd S. Adjunctive acetazolamide therapy for the treatment of Bartter syndrome. Int Urol Nephrol. 2020;52:121\u20138.","journal-title":"Int Urol Nephrol"},{"key":"370_CR60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21767\/2380-7245.100173","volume":"4","author":"A Kaur","year":"2018","unstructured":"Kaur A, Webb NJA, Shenoy M, Hulton SA. Bartter syndrome, 15-year experience in the United Kingdom. J Rare Disord Diagn Ther. 2018;4:1\u20137.","journal-title":"J Rare Disord Diagn Ther"}],"container-title":["World Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-020-00370-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12519-020-00370-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-020-00370-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T05:12:45Z","timestamp":1622524365000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12519-020-00370-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,1]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["370"],"URL":"https:\/\/doi.org\/10.1007\/s12519-020-00370-4","relation":{},"ISSN":["1708-8569","1867-0687"],"issn-type":[{"value":"1708-8569","type":"print"},{"value":"1867-0687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,1]]},"assertion":[{"value":"21 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Not needed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"No financial or nonfinancial benefits have been received or will be received from any party related directly or indirectly to the subject of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}